Cancer Research in Switzerland - Krebsliga Schweiz
Cancer Research in Switzerland - Krebsliga Schweiz
Cancer Research in Switzerland - Krebsliga Schweiz
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Basic biomedical research<br />
List of approved research projects <strong>in</strong> 2009/2010<br />
Total funds allocated: CHF 11,792,000.–<br />
Aguet Michel | KFS 02674082010 | CHF 234,400.–<br />
Institut suisse de recherche expérimentale sur le cancer (ISREC), Faculté des sciences de la vie, EPF de Lausanne,<br />
Lausanne<br />
Role of BCL9/BCL9L <strong>in</strong> regulat<strong>in</strong>g Wnt-mediated epithelial-mesenchymal transition, stem cell traits and drug<br />
sensitivity <strong>in</strong> Wnt-activated human cancers<br />
Basler Konrad | KFS 02443082009 | CHF 169,400.–<br />
Institut für molekulare Biologie, Universität Zürich, Zürich<br />
Characterization of the role of histone b<strong>in</strong>d<strong>in</strong>g by the WnT-signall<strong>in</strong>g components Pygo2 <strong>in</strong> mur<strong>in</strong>e models<br />
of breast cancer and colon cancer<br />
Becher Burkhard | KFS 02441082009 | CHF 203,000.–<br />
Institut für experimentelle Immunologie, Departement Pathologie, UniversitätsSpital Zürich, Zürich<br />
Cellular and molecular characterization of IL-12-mediated tumor suppression<br />
Boyman Onur | KFS 02672082010 | CHF 343,400.–<br />
Dermatologische Kl<strong>in</strong>ik, UniversitätsSpital Zürich, Zürich<br />
Precl<strong>in</strong>ical test<strong>in</strong>g of <strong>in</strong>terleuk<strong>in</strong>-2-antibody complexes for tumor immunotherapy<br />
Brisken Cathr<strong>in</strong> | KFS 02462082009 | CHF 331,200.–<br />
NCCR Molecular Oncology, Institut suisse de recherche expérimentale sur le cancer (ISREC), Faculté des sciences<br />
de la vie, EPF de Lausanne, Lausanne<br />
Mechanisms of action of progesterone <strong>in</strong> the human breast<br />
Brown Steven A. | KFS 02642082010 | CHF 240,100.–<br />
Institut für Pharmakologie und Toxikologie, Mediz<strong>in</strong>ische Fakultät, Universität Zürich, Zürich<br />
The mechanism of cancer and circadian clock <strong>in</strong>teractions and its usefulness <strong>in</strong> the design of therapeutic<br />
strategies<br />
Christofori Gerhard | KLS 02535022010 | CHF 283,200.–<br />
Institut für Biochemie und Genetik, Departement Biomediz<strong>in</strong>, Universität Basel, Basel<br />
The functional role of the transcription factors DIx2 and Lhx2 <strong>in</strong> epithelial-mesenchymal transition (EMT)<br />
and <strong>in</strong> malignant tumor progression<br />
Constam Daniel | KFS 02487082009 | CHF 307,600.–<br />
UPCDA, Institut suisse de recherche expérimentale sur le cancer (ISREC), Faculté des sciences de la vie,<br />
EPF de Lausanne, Lausanne<br />
Role of activ<strong>in</strong> signall<strong>in</strong>g <strong>in</strong> metastatic melanoma<br />
Dotto Gian-Paolo | OCS 02361022009 | CHF 314,350.–<br />
Département de biochimie, Faculté de biologie et de médec<strong>in</strong>e, Université de Lausanne, Epal<strong>in</strong>ges<br />
Tumor suppress<strong>in</strong>g function of calc<strong>in</strong>eur<strong>in</strong>/NFAT <strong>in</strong> kerat<strong>in</strong>ocytes<br />
Dufour Jean-François | KFS 02541022010 | CHF 202,200.–<br />
Institut für kl<strong>in</strong>ische Pharmakologie, Universität Bern, Bern<br />
Hepatocarc<strong>in</strong>ogenic roles of mTOR, raptor and rapamyc<strong>in</strong>s <strong>in</strong> absence of Pten<br />
Gönczy Pierre | KLS 02584022010 | CHF 197,000.–<br />
UPGON, Institut suisse de recherche expérimentale sur le cancer (ISREC), Faculté des sciences de la vie,<br />
EPF de Lausanne, Lausanne<br />
Mechanisms of centrosome duplication: From model organism towards therapeutic opportunities<br />
Grassi Fabio | KFS 02445082009 | CHF 144,000.–<br />
Istituto di ricerca biomedic<strong>in</strong>a (IRB), Bell<strong>in</strong>zona<br />
Pur<strong>in</strong>ergic signall<strong>in</strong>g <strong>in</strong> the pathophysiology of central nervous system <strong>in</strong>filtration <strong>in</strong> T-cell leukemia<br />
93